Call Now: +1 858 800 3101 Email: info@innopep.com
| Overview | |
|---|---|
| Description | This is the H-2Db restricted epitope derived from the lymphocytic choreomeningitis virus (LCMV) glycoprotein gp 33; residues 33 to 41. |
| Sequence | KAVYNFATM |
| Sequence (3 Letter) | H-Lys-Ala-Val-Tyr-Asn-Phe-Ala-Thr-Met-OH |
| Molecular Weight | 1044.3 |
| Properties | |
| Purity | > 95% By HPLC |
| Storage | Store at -20 °C, cap vial tightly at all times. |
Sasada, T. et al. J. Exp. Med. 194, 883 (2001); Kawamura, K. et al. J. Immunol. 168, 5709 (2002); Spiotto, M. and H. Schreiber Cancer Immunity 5, 8 (2005).
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.